Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; Postgraduate Program in Therapeutic Innovation, Biosciences Center, Federal University of Pernambuco, Recife, Brazil.
Postgraduate Program in Therapeutic Innovation, Biosciences Center, Federal University of Pernambuco, Recife, Brazil.
Clin Nutr ESPEN. 2023 Oct;57:207-212. doi: 10.1016/j.clnesp.2023.06.038. Epub 2023 Jun 29.
The ketogenic diet (KD) is a low-carb diet that has been indicated as a possible coadjuvant in cancer therapy, mainly due to its capacity to reduce glycolysis production, inflammation, and oxidative stress. However, KD's role in metastasis remains poorly explored. This study aims to provide a critical review of the literature about KD's efficacy in metastasis therapy and the possible molecular mechanisms behind it. Initially, general concepts on KD and metastasis are discussed. Then, it delves deeper into the main cancer mechanisms explored by KD experimental studies, discussing the central results obtained in metastasis research and their main limiting conditions. Following, there is a critical analysis of clinical trials, including those in the grey literature. In the end, there is a summary of the actual studies' limitations and barriers to future research. To date, it is possible to conclude that there is not enough evidence supporting the efficacy of KD in the treatment of metastasis.
生酮饮食(KD)是一种低碳水化合物饮食,已被证明可能是癌症治疗的辅助手段,主要是因为它能够降低糖酵解产物、炎症和氧化应激。然而,KD 在转移中的作用仍未得到充分探索。本研究旨在对 KD 在转移治疗中的疗效及其背后的可能分子机制进行文献综述。首先,讨论了 KD 和转移的一般概念。然后,深入探讨了 KD 实验研究中探索的主要癌症机制,讨论了转移研究中获得的主要中心结果及其主要的限制条件。接下来,对临床试验进行了批判性分析,包括灰色文献中的临床试验。最后,总结了实际研究的局限性和未来研究的障碍。迄今为止,可以得出的结论是,没有足够的证据支持 KD 在治疗转移方面的疗效。